Brain specific proteins in posthaemorrhagic ventricular dilatation

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 84, Issue 2, 2001, Pages

  Whitelaw, A ^a   Rosengren, L ^b   Blennow, M ^c  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Brain; Cerebrospinal fluid; Glial fibrillary acidic protein; Neurodevelopment; Posthaemorrhagic ventricular dilatation

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; PROTEIN S 100;

ARTICLE; BRAIN DEVELOPMENT; BRAIN HEMORRHAGE; BRAIN VENTRICLE DILATATION; CEREBROSPINAL FLUID EXAMINATION; CHILD DEATH; CLINICAL ARTICLE; DISABILITY; HUMAN; INFANT; NEUROFILAMENT; PREMATURITY; PRIORITY JOURNAL; SHUNTING;

EID: 0035085554     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/fn.84.2.f90     Document Type: Article

References (6)

1. Randomised trial of early tapping in neonatal posthaemorrhagic ventricular dilatation
2. Wikkelsö. Patients with amyotrophic lateral sclerosis, other neurodegenerative diseases have increased levels of neurofilament protein in CSF
3. Determination of S-100 and glial fibrillary acidic protein concentrations in cerebrospinal fluid after brain infarction
4. Glial fibrillary acid protein is increased in the cerebrospinal fluid of pre-term infants with abnormal neurological findings
5. S-100 protein and neuron-specific enolase in cerebrospinal and serum: Markers of cell damage in human central nervous system
6. A sensitive ELISA for glial fibrillary acidic protein: Applications in CSF of adults